Life Science Leader — April 2013 Outsourcing and the oral solid dose: Will challenges lead to new patterns of outsourcing? Life Science Leader — CRO Leadership Awards supplement issue Strategic Outsourcing Often Means Combining Functional and Full-Service CROs 
 
May 10 Life Science Leader's May issue includes results from Nice Insight annual research April 10 Learn about Trends in Outsourcing the Oral Solid Dose in April's Outsourcing Insights 
"In the past, if you wanted this type of information, you hired a
third-party agency to survey your customers. Not only did you pay a third
party to collect the data, but you wondered how good was it really? Even
though you hired an outside company, customers filling out the survey still
knew who was sponsoring the research."
PAUL SIDHU VP OF MARKETING AND STRATEGY FOR DSM  
BioProcess International Conference
September 16-20 Boston, MA |
Albemarle Corporation BASF Chempacific Corporation Dottikon Exclusive Synthesis FutureFuel Haupt Pharma AG Monument Chemical PennAKem LLC Jubilant Chemsys
Jubilant Chemsys, a part of Jubilant Drug Discovery and Development Services under the flagship of Jubilant Life Science Limited, offers services in synthetic organic and medicinal chemistry to various pharmaceutical and biotechnology companies. Supported by a platform of confidentiality and intellectual property protection, services are designed to assist our customers to meet cost effectiveness and efficiency. The company’s scientific team is supported by strong infrastructure to facilitate complex syntheses at small and large scale, and address SAR needs for Medicinal Chemistry programs. http://www.jchemsys.com/
Regions
Asia, Europe Stock Symbol Private Filter of Jubilant Chemsys's services per Nice Insight Categories
Contact Jubilant Chemsys 
|
|
|
